180 related articles for article (PubMed ID: 29142475)
1. Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors.
Cai B; Broder MS; Chang E; Yan T; Metz DC
World J Gastroenterol; 2017 Oct; 23(40):7283-7291. PubMed ID: 29142475
[TBL] [Abstract][Full Text] [Related]
2. [Pathological implications in the neuroendocrine gastrointestinal system].
Piette C; Polus M; Louis E
Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
[TBL] [Abstract][Full Text] [Related]
4. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry.
Palepu J; Shrikhande SV; Bhaduri D; Shah RC; Sirohi B; Chhabra V; Dhar P; Sastry R; Sikora S
Indian J Gastroenterol; 2017 Nov; 36(6):445-451. PubMed ID: 29457213
[TBL] [Abstract][Full Text] [Related]
5. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
[TBL] [Abstract][Full Text] [Related]
6. Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly Patients.
Shen C; Chu Y; Halperin DM; Dasari A; Zhou S; Xu Y; Yao JC; Shih YT
Oncologist; 2017 Dec; 22(12):1451-1462. PubMed ID: 28642335
[TBL] [Abstract][Full Text] [Related]
7. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
8. [Comparison and analysis of the clinical features of different types of gastrointestinal cancers].
Hu YQ; Qian JM; Zhou XD
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):900-2. PubMed ID: 15730733
[TBL] [Abstract][Full Text] [Related]
9. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
10. Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.
Rinzivillo M; Capurso G; Campana D; Fazio N; Panzuto F; Spada F; Cicchese N; Partelli S; Tomassetti P; Falconi M; Delle Fave G
Neuroendocrinology; 2016; 103(5):531-7. PubMed ID: 26356731
[TBL] [Abstract][Full Text] [Related]
11. Healthcare and economic impact of diarrhea in patients with carcinoid syndrome.
Broder MS; Chang E; Romanus D; Cherepanov D; Neary MP
World J Gastroenterol; 2016 Feb; 22(6):2118-25. PubMed ID: 26877616
[TBL] [Abstract][Full Text] [Related]
12. EPIDEMIOLOGY OF GASTROINTESTINAL NEUROENDOCRINE TUMORS IN A U.S. COMMERCIALLY INSURED POPULATION.
Broder MS; Cai B; Chang E; Neary MP
Endocr Pract; 2017 Oct; 23(10):1210-1216. PubMed ID: 28704096
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L
Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832
[TBL] [Abstract][Full Text] [Related]
14. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors.
Kamp K; Alwani RA; Korpershoek E; Franssen GJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2016 Mar; 174(3):271-80. PubMed ID: 26643855
[TBL] [Abstract][Full Text] [Related]
16. Cervical and upper mediastinal lymph node metastasis from gastrointestinal and pancreatic neuroendocrine tumors: true incidence and management.
Wang YZ; Mayhall G; Anthony LB; Campeau RJ; Boudreaux JP; Woltering EA
J Am Coll Surg; 2012 Jun; 214(6):1017-22. PubMed ID: 22521444
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
[TBL] [Abstract][Full Text] [Related]
18. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
Allan B; Davis J; Perez E; Lew J; Sola J
Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
[TBL] [Abstract][Full Text] [Related]
19. Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis.
Benson AB; Broder MS; Cai B; Chang E; Neary MP; Papoyan E
World J Gastroenterol; 2017 Sep; 23(33):6128-6136. PubMed ID: 28970728
[TBL] [Abstract][Full Text] [Related]
20. Economic analysis of inadequate symptom control in carcinoid syndrome in the United States.
Burton T; Lapuerta P
Future Oncol; 2018 Oct; 14(23):2361-2370. PubMed ID: 30095284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
